Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability

Authors
Publication date
1 January 2016
Publisher
Doi
    View on PubMed

    Abstract

    Demonstrate rapid initiation of co-formulated treatment during acute HIV infection (AHI) is feasible and efficacious

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:zp38wj376
      Last time updated on 02/04/2020